USANA Health Sciences, Inc. (NYSE:USNA) Stock Rating Lowered by BidaskClub

BidaskClub downgraded shares of USANA Health Sciences, Inc. (NYSE:USNA) from a hold rating to a sell rating in a research note published on Thursday, November 2nd.

Separately, Pivotal Research cut their price objective on USANA Health Sciences from $75.00 to $70.00 and set a buy rating on the stock in a research report on Wednesday, July 26th.

USANA Health Sciences (USNA) opened at $65.95 on Thursday. The stock has a market capitalization of $1,579.91, a P/E ratio of 17.42 and a beta of 1.07. USANA Health Sciences has a one year low of $52.55 and a one year high of $71.00.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The firm had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. During the same quarter in the prior year, the firm earned $2.40 EPS. USANA Health Sciences’s quarterly revenue was up 3.0% on a year-over-year basis. analysts anticipate that USANA Health Sciences will post 3.7 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “USANA Health Sciences, Inc. (NYSE:USNA) Stock Rating Lowered by BidaskClub” was reported by BBNS and is the property of of BBNS. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://baseballnewssource.com/markets/usana-health-sciences-inc-usna-stock-rating-lowered-by-bidaskclub/1750614.html.

USANA Health Sciences declared that its board has approved a share buyback program on Tuesday, July 25th that permits the company to repurchase $64.60 million in shares. This repurchase authorization permits the company to repurchase up to 46% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

In other USANA Health Sciences news, major shareholder Global Ltd Gull sold 60,871 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, October 26th. The stock was sold at an average price of $67.39, for a total value of $4,102,096.69. Following the completion of the transaction, the insider now directly owns 12,089,267 shares in the company, valued at $814,695,703.13. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Myron W. Wentz sold 5,304 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $66.01, for a total value of $350,117.04. Following the sale, the director now directly owns 12,011,418 shares in the company, valued at approximately $792,873,702.18. The disclosure for this sale can be found here. Insiders sold 557,067 shares of company stock valued at $34,451,431 over the last quarter. Insiders own 53.20% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Northern Trust Corp raised its holdings in USANA Health Sciences by 10.5% during the second quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock worth $11,386,000 after purchasing an additional 16,948 shares in the last quarter. American International Group Inc. raised its holdings in USANA Health Sciences by 7.1% during the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock worth $368,000 after purchasing an additional 422 shares in the last quarter. Trust Co. of Vermont raised its holdings in USANA Health Sciences by 482.7% during the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after purchasing an additional 3,900 shares in the last quarter. Schroder Investment Management Group grew its position in USANA Health Sciences by 9.0% in the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after buying an additional 47,448 shares during the last quarter. Finally, FMR LLC grew its position in USANA Health Sciences by 3.9% in the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after buying an additional 60,033 shares during the last quarter. 44.54% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Brandon Morrow Becomes Hot Commodity
Brandon Morrow Becomes Hot Commodity
Red Sox Want Sluggers, Giancarlo Stanton May Become Available
Red Sox Want Sluggers, Giancarlo Stanton May Become Available


Leave a Reply

 
© 2006-2017 BBNS.